-+ 0.00%
-+ 0.00%
-+ 0.00%

LAKEFRONT BIOTHERAPEUTICS NV - GAMGERTAMIG IN PHASE 2 STUDIES; REGISTRATION STUDIES EXPECTED IN 2027

Reuters·08/24/2026 20:01:00

Please log in to view news